Investigators map genomic landscape of very rare cancer

by Tom Wilemon,Vanderbilt UniversityKiller T cells surround a cancer cell. Credit: NIHA team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tr

Oncology June 15,2024

Investigators map genomic landscape of very rare cancer

by Tom Wilemon,Vanderbilt UniversityKiller T cells surround a cancer cell. Credit: NIHA team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tr

Oncology June 15,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Oncology June 15,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Oncology June 15,2024

Researchers convert pro-tumor macrophages into cancer killers

by University of California - San DiegoCredit: CC0 Public DomainEpithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer ther

Oncology June 15,2024

Researchers convert pro-tumor macrophages into cancer killers

by University of California - San DiegoCredit: CC0 Public DomainEpithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer ther

Oncology June 15,2024

Investigators find strong association of kidney injury with dasatinib, a commonly used oncological therapeutic

by The Mount Sinai HospitalCredit:Clinical Journal of the American Society of Nephrology(2023). DOI: 10.2215/CJN.0000000000000219Investigators have found that dasatinib, a drug common

Nephrology & Urology June 15,2024

Investigators find strong association of kidney injury with dasatinib, a commonly used oncological therapeutic

by The Mount Sinai HospitalCredit:Clinical Journal of the American Society of Nephrology(2023). DOI: 10.2215/CJN.0000000000000219Investigators have found that dasatinib, a drug common

Nephrology & Urology June 15,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Oncology June 15,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Oncology June 15,2024

Researchers examine the metabolic effects of an oral blood cancer drug

by The Mount Sinai HospitalCredit: CC0 Public DomainA popular cancer drug is associated with significant weight gain and increased systolic blood pressure, researchers from the Icahn School of Me

Oncology June 15,2024

Researchers examine the metabolic effects of an oral blood cancer drug

by The Mount Sinai HospitalCredit: CC0 Public DomainA popular cancer drug is associated with significant weight gain and increased systolic blood pressure, researchers from the Icahn School of Me

Oncology June 15,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Oncology June 15,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Oncology June 15,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Oncology June 15,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Oncology June 15,2024

Researchers unveil experimental compound to block therapeutic target in blood cancer

by UNC Lineberger Comprehensive Cancer CenterBlossom Damania, PhD, Jason Wang and a team of UNC Lineberger researchers report in PNAS they have discovered a hyperactive cell signal that contribut

Oncology June 15,2024

Researchers unveil experimental compound to block therapeutic target in blood cancer

by UNC Lineberger Comprehensive Cancer CenterBlossom Damania, PhD, Jason Wang and a team of UNC Lineberger researchers report in PNAS they have discovered a hyperactive cell signal that contribut

Oncology June 15,2024

Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Oncology June 15,2024

Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Oncology June 15,2024